A new self: MHC-class-I-independent Natural-killer-cell self-tolerance
- 20 April 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 5 (5), 363-374
- https://doi.org/10.1038/nri1603
Abstract
A fundamental tenet of the immune system is the requirement for lymphocytes to respond to transformed or infected cells while remaining tolerant of normal cells. Natural killer (NK) cells discriminate between self and non-self by monitoring the expression of MHC class I molecules. According to the 'missing-self' hypothesis, cells that express self-MHC class I molecules are protected from NK cells, but those that lack this self-marker are eliminated by NK cells. Recent work has revealed that there is another system of NK-cell inhibition, which is independent of MHC class I molecules. Newly discovered NK-cell inhibitory receptors that have non-MHC-molecule ligands broaden the definition of self as seen by NK cells.Keywords
This publication has 99 references indexed in Scilit:
- The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophilsEuropean Journal of Immunology, 2004
- The LLT1 receptor induces IFN-γ production by human natural killer cellsMolecular Immunology, 2004
- Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1The Journal of Experimental Medicine, 2004
- Immune functions encoded by the natural killer gene complexNature Reviews Immunology, 2003
- Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibilityHuman Genetics, 2003
- Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary PerspectiveChemical Reviews, 2002
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)The Journal of Experimental Medicine, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989